SCHEMBL4124207

SCHEMBL4124207

COC(=O)c1sc2cc(-c3cccc(N)c3)ccc2c1OCC(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 3/20 0.39
ALDH1A1 P00352 3/20 0.39
GLA P06280 2/20 0.39
ALOX15 P16050 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPK1 P28482 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTPN1 P18031 1/20 0.38
LIMK1 P53667 4/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
MCL1 Q07820 1/20 0.35
LMNA P02545 3/20 0.35
F9 P00740 1/20 0.35
F10 P00742 1/20 0.35
LIPG Q9Y5X9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119302 0.90 LIPG (0.42) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4126920 0.89 PTPN1 (0.37) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4131424 0.86 MAPT (0.37) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4131737 0.86 L3MBTL1 (0.41) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4130360 0.84 MCL1 (0.43) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4118848 0.83 NR4A2 (0.40) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4123046 0.83 EGLN1 (0.40) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL4124240 0.83 GABRA1 (0.42) MAPTKDM4EALDH1A1HSD17B10MAPK1
SCHEMBL4118492 0.82 MAPK1 (0.37) MAPTKDM4EHPGDALDH1A1GLA
SCHEMBL25036186 0.82 PTPN1 (0.45) MAPTKDM4EHPGDALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B WYETH (US) 2009-02-19 US disclosed
US-20050203081-A1 Inhibitors of protein tyrosine phosphatase 1B WYETH 2005-09-15 US disclosed
WO-2005081960-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B WYETH (US) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203081-A1 Inhibitors of protein tyrosine phosphatase 1B PTPRS, PTPRO, PTPRM MAPT 3303/4885KDM4E 899/4885HPGD 3685/4885
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B PTPRS, PTPRO, PTPRM MAPT 3303/4885KDM4E 899/4885HPGD 3685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.